Gordon Haskett News

25.02 / 09:36
markets Target Boeing wellness Trade performer Headlines Street Calls of the Week: Compass downgrade - risk greater than reward
Investing.com — Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrade for Coty, downgrades for Alkermes, Compass and Boeing.
08.10 / 14:31
markets COST CEO Strategy Pfizer performer Pharmaceuticals Pfizer CEO’s job is at risk. A shot of discipline could help.
Subscribe to enjoy similar stories. When former executives team up with an activist investor to “help" a struggling company, it is often bad news for the current chief executive. That is one implication behind activist investor Starboard Value’s $1 billion stake and its push to make changes at Pfizer, which The Wall Street Journal reported has support from former Pfizer Chief Executive Ian Read and former Chief Financial Officer Frank D’Amelio.

details regarding Gordon Haskett

Who is Gordon Haskett?

Gordon Haskett is a notable individual featured in various news reviews related to trending topics.

Why is Gordon Haskett attracting attention?

Gordon Haskett frequently draws public interest due to widely discussed behavior, which captures media coverage.

Where can I find the latest news about Gordon Haskett?

Our website has a dedicated section featuring all recent updates related to Gordon Haskett. We continuously monitor developments and update the information as it becomes available.